RxDoctor Payments Data

David Okonkwo, MD

Neurological Surgery · Pittsburgh, PANPI 1447204854

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.3%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. Globus Medical accounts for 80.0% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $621,460 and has fallen 51.1% since, to $303,604 in 2025. Among neurological surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,307,771in general payments, 2019–2025

Across 443 payments — averaging $5209.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$1.8M
  • Zimmer Biomet$400K
  • Zimvie Inc.$32K
  • Stryker$9K
  • Highridge Medical LLC$8K
  • Siemens Medical Solutions USA, Inc.$6K
  • plus $7K from 11 others
$45,134in research payments, 2019–2025

Across 27 payments — averaging $1671.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mitsubishi Tanabe Pharma Development America, Inc.$29K
  • Abbott$6K
  • Tanabe Pharma America, Inc.$5K
  • Avanir Pharmaceuticals, Inc.$3K
  • Vertex$2K
$150,000in ownership & investment interests, 2019–2025

Across 6 payments — averaging $25,000 each. An ownership or investment interest held by the physician or an immediate family member.

  • Durastat LLC$150K
  • Globus Medical$0

What the payments were for

  • Royalty or licence$859,41737%
  • Consulting fees$1,206,50052%
  • Speaking & faculty fees$170,6037%
  • Travel & lodging$55,5282%
  • Food & beverage$15,7231%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,307,771 in reported general payments places this provider in the 95th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$204,411
Medicare patients
169
Services billed
569

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin21$124

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →